Trazodone

Serotonin Modulator (Antidepressant)

NADAC/unit $0.0335

No Shortage Tier 1: 294.5% 12 Manufacturers 40 ANDAs

Trazodone is a selective serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) ( 1 ).

Covered Lives

Market Intelligence

2026-02-11 Class II Recall: Granules Pharmaceuticals Inc.

2026-01-07 Class III Recall: Zydus Pharmaceuticals (USA) Inc

Generic Manufacturers

ACCORD HEALTHCARE INCAPOTEX INCAUROBINDO PHARMA LTDCROSSMEDIKA SAGRANULES INDIA LTDGRAVITI PHARMACEUTICALS PRIVATE LTDKAMAT PHARMATECH LLCOXFORD PHARMACEUTICALS LLCPLIVA INCSUN PHARMACEUTICAL INDUSTRIES INCTEVA PHARMACEUTICALS USA INCTORRENT PHARMACEUTICALS LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Trazodone drfinder.aiFind doctors who prescribe Trazodone rxnews.aiLatest news about Trazodone

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.